Sigma Healthcare Reports Revenue Growth but Faces Financial Challenges

The latest update is out from Sigma Healthcare Ltd ( (AU:SIG) ).

Sigma Healthcare Ltd reported a significant increase in sales revenue by 45.7% for the year ending January 31, 2025, reaching $4.84 billion. Despite the revenue growth, the company experienced a net loss after tax of $12.9 million, attributed to a decrease in statutory EBIT and net tangible asset backing per share. The company declared no final dividend for the year, reflecting a cautious approach amid financial challenges.

More about Sigma Healthcare Ltd

Sigma Healthcare Ltd operates in the healthcare industry, focusing on the distribution of pharmaceutical products and services. The company is a key player in the Australian market, providing a wide range of healthcare solutions.

YTD Price Performance: 7.01%

Average Trading Volume: 8,058

Technical Sentiment Consensus Rating: Sell

Current Market Cap: €19.7B

Find detailed analytics on SIG stock on TipRanks’ Stock Analysis page.